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Abstract
Purpose: The aim of the current study was to survey if vowel articulation in speakers with Parkinson’s disease (PD) shows
specific changes in the course of the disease.
Method: 67 patients with PD (42 male) and 40 healthy speakers (20 male) were tested and retested after an average time
interval of 34 months. Participants had to read a given text as source for subsequent calculation of the triangular vowel
space area (tVSA) and vowel articulation index (VAI). Measurement of tVSA and VAI were based upon analysis of the first and
second formant of the vowels /a/, /i/and /u/ extracted from defined words within the text.
Results: At first visit, VAI values were reduced in male and female PD patients as compared to the control group, and
showed a further decrease at the second visit. Only in female Parkinsonian speakers, VAI was correlated to overall speech
impairment based upon perceptual impression. VAI and tVSA were correlated to gait impairment, but no correlations were
seen between VAI and global motor impairment or overall disease duration. tVSA showed a similar reduction in the PD as
compared to the control group and was also found to further decline between first and second examination in female, but
not in male speakers with PD.
Conclusions: Measurement of VAI seems to be superior to tVSA in the description of impaired vowel articulation and its
further decline in the course of the disease in PD. Since impairment of vowel articulation was found to be independent from
global motor function but correlated to gait dysfunction, measurement of vowel articulation might have a potential to serve
as a marker of axial disease progression.
Citation: Skodda S, Gro ¨nheit W, Schlegel U (2012) Impairment of Vowel Articulation as a Possible Marker of Disease Progression in Parkinson’s Disease. PLoS
ONE 7(2): e32132. doi:10.1371/journal.pone.0032132
Editor: Kevin Paterson, University of Leicester, United Kingdom
Received August 14, 2011; Accepted January 24, 2012; Published February 28, 2012
Copyright:  2012 Skodda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sabine.skodda@kk-bochum.de
Introduction
Hypokinetic dysarthria in Parkinson’s disease (PD) is a
multidimensional impairment affecting all different aspects of
speech as speech respiration, phonation, articulation and prosody
[1,2]. Imprecise vowel articulation has been shown to be present
even in mild stages of PD [3] and commonly contributes to
reduced speech intelligibility [1,4,5]. Kinematic and acoustic
measurements revealed that PD patients produce ‘‘undershooting’’
of articulatory gestures [1,6,7] which lead amongst others to
imprecise articulation of consonants and vowels [8,9]. Further-
more, several studies provide kinematic evidence of reduced
amplitude and velocity of lip, tongue and jaw movements (the so
called ‘‘articulators’’), which may represent the physiological basis
of hypokinesia and rigidity of the vocal tractus [6,10,11] or may be
related to deficits in scaling amplitude, impaired internal cueing
and abnormal perception [12]. Evidence from acoustic studies also
supports the conclusion that the reduced range of articulator
movements in PD leads to imprecise vowel articulation caused by
impaired and less distinctive ‘‘formant’’ generation [13].
Vowels are formed primarily by movements of the articulators
creating oropharyngeal resonating cavities which amplify certain
frequency bands of the voice spectrum. These harmonics (the so
called ‘‘formants’’) define the single vowels by their typical distinct
peaks of acoustic energy. The position of the articulators therefore
defines the three dimensional characteristics of the vocal tractus
and influences the formant frequencies, especially of the first (F1)
and second (F2) formant. Frequencies of F1 and F2 are mainly
defined by the tongue position with the simplified ‘‘rule’’ that the
F1 frequency is inversely related to the height of the tongue
whereas the F2 frequency is directly related to the frontness of the
tongue position [14]. As a consequence, limited movements of the
articulators and particularly of the tongue, as suggested in PD, lead
to inadequate vowel formation by a restriction of formant
production which should be characterized by a lowering of
normally high frequency formants and by an elevation of normally
low frequency formants [15]. This hypothesised constriction of
working space for vowels in PD should be mirrored by a reduction
of the triangular vowel space area (tVSA) which can be assessed by
plotting the F1 frequency as a function of F2 frequency for the
three corner vowels /a/, /i/ and /u/ to provide a graphic display
of a vowel triangle (see figures 1 and 2). The area of the vowel
triangle can be calculated according to the following formula:
tVSA=abs((F1_/i/ * (F2_/a/2F2_/u/)+F1_/a/ * (F2_/u/
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e321322F2_/i/)+F1_/u/ * (F2_/i/2F2_/a/)/2). The absolute Hz
2
values of vowel area obtained through this calculation do not
possess functional significance on their own, although they are
estimated to serve as an index of the general pattern of change in
the working space for vowels [16,17,18]. However, measurement
of the triangular or quadrilateral VSA, although well established as
the most common acoustic metric in research on disturbed vowel
articulation (e.g. [13,19]), has been proven to be insensitive to mild
or moderate forms of dysarthria, especially in PD patients [4].
Moreover, in some studies, the VSA accounted for only about
10% of the variance in measures of speech intelligibility [20,21].
Recently, a further surrogate parameter called ‘‘vowel articulation
index/VAI’’ (and its reciprocal value, the so called ‘‘formant
centralization ratio/FCR’’) had been developed by Sapir and
coworkers [15,18] and been proven by empirical testing to be
more sensitive in Parkinsonian hypokinetic dysarthria than tVSA
in several publications [15,18,22]. VAI can be calculated by the
following formula: VAI=(F2/i/+F1/a/)/(F1/i/+F1/u/+F2/u/
+F2/a/). Formant concentration caused by a reduction of
articulator movements in Parkinsonian speakers is therefore
expected to lead to a decrease of the numerator (F2/i/+F1/a/)
and an increase of the denominator (F1/i/+F1/u/+F2/u/+F2/a/)
resulting in an overall reduction of VAI. This hypothesis has been
confirmed in a previous investigation of VAI in Parkinsonian
patients without any or only mild degrees of dysarthria [3].
According to a previous investigation on a large sample of
speakers with PD, disturbance of voice may be an early and
predominant feature and is complemented by additional impair-
ment of fluency and articulation in the more severe stages of the
disease [23]. Concerning overall motor deterioration in PD, global
motor function was reported to show an annual decline of about
3% in one population-based study [24]; though, different courses
of disease progression were found when related to the age of onset
with a faster decline of mentation and gait in the older-onset group
[25]. On the other hand, positron emission tomographic imaging/
PET-based studies suggested a negative exponential course of
progression at least when related to dopaminergic neurodegener-
ation [26,27]. These ostensible discrepancies between the clinical
course of disease progression and findings of functional imaging
based investigations might be explained by the fact that PET
Figure 1. Exemplified comparison of the first and second formant frequencies (F1 and F2) of the vowels /a/, /i/ and /u/ of a healthy
speaker. The F1 and F2 frequencies are marked in light (F1) and dark (F2) grey. x-axis: time; y-axis: frequency (in hertz).
doi:10.1371/journal.pone.0032132.g001
Figure 2. Exemplified triangular vowel space area (tVSA) of a healthy speaker and a patient with PD (dotted triangle).
doi:10.1371/journal.pone.0032132.g002
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interest and neurotransmitter systems which do not necessarily
mirror the overall disease progression observed in clinical surveys.
Besides these considerations about overall disease progression in
PD, little is known about the development of different speech
modalities in the course of the disease in the individual patient
with only single studies documenting a deterioration of distinct
prosodic speech dimensions as pitch variability, speech rate and
stability of syllable repetition which seem to rather arise after a
longer disease duration without correlation to global motor
function [28,29].
To gain additional insight into the development of further
aspects of speech in PD, the aim of the present study was the
investigation of vowel articulation in the course of the disease in
the individual patient and to test for correlations with global
motor, gait and speech impairment. According to our hypothesis,
a deterioration of global speech impairment in the course of the
disease as assessed by perceptual rating should be mirrored by a
decrease of tVSA and VAI as surrogate parameters for
distinctiveness of vowel articulation. A second aim of the present
investigation was to survey, if measurement of VAI turns out to be
superior to tVSA in the detection of subtle changes of vowel
articulation over time as it has to be supposed according to
previous studies.
Methods
Our study was in compliance with the Helsinki Declaration and
had been approved by the Ethics Committee of the Ruhr
University Bochum. Written informed consent was obtained from
each participant.
From 2002 to 2011, 67 patients (42 male, 25 female) with
idiopathic Parkinson’s disease (PD) were recruited for this study. The
diagnosis of PD was based upon clinical criteria according to the
UK Parkinson’s Disease Society Brain Bank Criteria [30].
Patients’ age on first examination ranged from 40 to 80 years
(mean: 66.27/median: 67/SD: 7.95). Idiopathic Parkinson’s
disease had been diagnosed from 1 to 20 years prior to the first
examination (mean 6.12/median 5/SD: 4.53). Time between first
and second examination ranged from 12 to 88 months (mean:
34.06/median: 30/SD: 20.35). On both visits, each patient
underwent a neurological examination, according to UPDRS
Motor Score/UPDRS III (UPDRSt0: mean: 19.48/median: 18/
SD: 10.74/range: 4 to 57 points; UPDRSt1: mean: 19.10/median:
18/SD: 8.28/range: 5 to 40 points) and was scored according to
Hoehn&Yahr Scale (H&Yt0: mean: 2.07/median: 2/SD: 0.36/
range: 1.5 to 3 points; H&Yt1: mean: 2.57/median: 2.5/SD: 0.63/
range: 1.5 to 4 points) before performing the speech task. Item 18
of the UPDRS Motor Score (‘‘speech’’) was taken for global
perceptual description of patients’ speech (UPDRSspeech_t0: mean:
0.96/median: 1/SD: 0.66/range: 0 to 2 points; UPDRSspeech_t1:
mean: 1.36/median: 1/SD: 0.87/range: 0 to 3 points). Items 27–30
were taken for the description of posture and gait (UPDRSgait_t0:
mean: 1.52/median: 1/SD: 1.41/range: 0 to 5 points; UP-
DRSgait_1: mean: 2.78/median: 2/SD: 1.68/range: 0 to 7 points).
Furthermore, levodopa equivalence doses/LED were given for the
first and second examination [31] (LEDt0: mean: 563 mg/median:
550 mg/SD: 166/range: 175 to 900 mg; LEDt1: mean: 723 mg/
median: 700 mg/SD: 207; range: 300 to 1325 mg).
A subgroup of 38 patients and 15 controls had participated in a
previous study on speech performance [28]. At the time of the
examination, patients were on stable dopaminergic medication
since at least 4 weeks prior to the examination. Speech and motor
examinations were performed 60 to 90 minutes after the morning
dose of medication to ensure the ‘‘on’’-state. None of the patients
experienced orofacial or abdominothoracic peak-dose dyskinesia
during the examination. Medication with anticholinergics, cholin-
esterase inhibitors and atypical neuroleptics and severe dementia
(MMSE,25 pts.) were exclusion criteria.
As control group we tested and re-tested 40 age-matched healthy
persons (mean age 67.69 years/median 67.5 years/SD: 6.10/
range 55 to 80 years; 20 male, 20 female) which were re-tested
after a mean time period of 21.36 months (median 20/SD 6.16/
range 12 to 36 months).
None of the participants suffered from relevant hearing
impairment as assessed by a hearing screening test (exposition to
test sounds prior to the definite examination).
Each participant had to perform a standardized reading task
composed of four complex sentences which had been used by our
group in previous research on Parkinsonian dysarthria [3,28]
(Supporting Information S1). In order to get more familiar with
the text and to exclude difficulties in reading, the participants had
to read the text twice; the second sequence was taken for the
definite analysis. All participants were native German speakers.
Speech samples were digitally recorded and anonymized by our
Parkinson nurse in a quiet room using a commercial audio soft-
ware (Steinberg WaveLab, Steinberg Media Technologies
GmbH, Hamburg, Germany) and a head-set microphone
(Plantronics Audio 550 DSP, Plantronics Inc., California
95060, USA) positioned 5 cm from the lips. The data were digi-
tized at a sampling rate of 44.1 kHz. Each of the vowels /a/, /i/
and /u/ were extracted 10 times from different defined words
within the text. The formant frequency values F1 and F2 were
measured separately for each vowel for a 30 ms segment at the
temporal midpoint using a special speech software (Praat) [32].
For each vowel, the average formant frequency values of F1 and
F2 were calculated based upon the separate ten measurements
(tables 1+2). These average values were taken for the calculation of
tVSA and VAI. The examiner who performed the acoustical
analysis (S.S.) was blind to participants’ condition.
Winstat (Bad Krotzingen/Germany) was used for statistical
analyses. ANOVA with post-hoc t-test for independent (PD vs.
control) and dependent (t0 vs. t1) samples was performed, since the
variables were widely normally distributed (Kolmogorov-Smirnov-
Test). Pearson correlation was used to test for significant
correlations. The adjusted level of significance was set as p,0.01.
Results
Detailed numerical data of participants’ characteristics and
speech parameters are listed in tables 1+2 and 3+4/figure 3 and 4.
According to ANOVA, condition (PD vs. control) and gender
were shown to be independent factors for tVSA and VAI
(p,0.001 respectively). Therefore, a gender-related analysis and
comparison with the accordant control group was performed.
PD group as a whole
No correlations were seen between the LEDs at first and second
examination and tVSA and VAI. However, there was a correlation
between the difference of the total UPDRS score (DUPDRS) and
the difference of LED (DLED) between t0 and t1 (R=0.455,
p,0.0001). Concerning H&Y stages and the UPDRS gait subscore,
there were only trends to an inverse correlation to DLED.
Male group
No significant differences concerning age at t0 were seen
between the male PD group and the control group, however, the
time interval between first and second examination was shorter in
Vowel Articulation in the Course of PD
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remained stable over time, whereas in the PD group, there was a
significant reduction of VAI at t1 as compared to t0 (p,0.0001)
which was not observed in tVSA. Inter-group comparison revealed
no relevant differences of VAI between PD and control group at t0
(p=0.08), but a significant reduction at t1 in the PD group when
compared to the control group (p,0.0001). tVSA in the PD group
was found to be reduced when compared to the control group only
at t1 (p=0.050) without reaching adjusted level of significance.
No correlations were seen between tVSA or VAI and disease
duration, time interval between t0 and t1, UPDRS III and UPDRS
speech item. However, there were weak negative correlations
between total UPDRS and UPDRS gait subscore and VAI at t1
(R=20.386, p=0.006 and R=20.290, p,0.05) and a clear
negative correlation between the difference of VAI (DVAI) and the
difference between the UPDRS gait subscores (DUPDRSgait)a tt 0
and t1 (R=20.657, p,0.0001). A similar but weaker correlation
was seen between DUPDRSgait and DtVSA (R=20.273, p=0.05).
Female group
No significant differences concerning age at t0 were seen
between the female PD group and the control group, however, the
time interval between first and second examination was shorter in
the control group (p=0.005). In the control group, VAI and tVSA
remained stable over time, whereas in the female PD group, there
was a significant reduction of VAI at t1 as compared to t0 (p=0.001)
which was also seen for tVSA (p=0.0003). Inter-group comparison
revealed no significant differences of tVSA and VAI between PD
and control group at t0 (VAI: p=0.06; tVSA: p=0.127), but a
significant reduction at t1 in the PD group when compared to the
control group (VAI: p,0.0001, tVSA: p=0.0002).
No correlations were seen between tVSA or VAI and disease
duration, time interval between t0 and t1 and UPDRS III, however,
global speech impairment according the UPDRS speech item
showed a correlation to VAI (but not to tVSA) at t0 (R=20.535,
p=0.003) and t1 (R=20.558, p=0.002) as well. The UPDRS gait
subscore was correlated to VAI at t0 (R=20.508, p=0.005), but
not at t1. A similar, but weaker correlation was also found between
tVSAt0 and the UPDRS gait subscores (R=20.415, p=0.019).
Furthermore, there was a negative correlation between DVAI and
DUPDRSgait (R=20.491, p=0.006) and between DtVSA and
DUPDRSgait respectively (R=20.537, p=0.003).
The average formant frequency values for the single vowels are
listed in tables 1+2 with a supplementary display of normative data
from literature based upon German vowels extracted from speech
material of a sample of n=69 male and n=58 female subjects
Table 2. Female participants: average formant frequency values which were the source for the calculation of VAI and tVSA
(table 4).
PD female (n=25) Control female (n=20)
published data
[27]
t0 t1 t0 t1
mean S.D. mean S.D. mean S.D. mean S.D. mean S.D.
F1_/a/ 671.89 75.93 665.95 76.11 701.89 85.19 692.71 81.81 836 135
F2_/a/ 1552.12 80.79 1552.81 77.64 1550.07 92.29 1561.22 89.32 1586 156
F1_/i/ 334.63 28.91 347.56 30.37 328.11 45.57 331.12 50.10 433 85
F2_/i/ 2221.39 174.18 2204.85 163.40 2323.01 118.27 2319.29 111.74 2095 259
F1_/u/ 359.01 46.94 408.09 57.09 371.70 69.72 369.42 61.16 442 85
F2_/u/ 1169.39 120.49 1315.87 117.78 1171.02 141.45 1180.82 132.11 1081 183
VAI 0.827
tVSA 100,273
doi:10.1371/journal.pone.0032132.t002
Table 1. Male participants: average formant frequency values which were the source for the calculation of VAI and tVSA (table 3).
PD male (n=42) Control male (n=20) published data [27]
t0 t1 t0 t1
mean S.D. mean S.D. mean S.D. mean S.D. mean S.D.
F1_/a/ 524.45 86.13 559.24 92.35 582.58 94.69 577.43 96.14 694 95
F2_/a/ 1330.86 108.59 1400.93 131.93 1322.49 109.85 1330.01 99.72 1372 153
F1_/i/ 312.47 51.21 386.99 223.03 305.31 35.82 311.52 42.11 369 111
F2_/i/ 1979.96 96.57 1997.16 139.04 2023.17 109.68 2009.22 101.34 1902 207
F1_/u/ 378.90 92.26 456.87 135.00 389.78 73.60 382.65 76.44 310 82
F2_/u/ 1320.65 220.06 1573.35 279.30 1376.20 280.63 1385.64 261.62 854 205
VAI 0.894
tVSA 185,935
doi:10.1371/journal.pone.0032132.t001
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performed in order to avoid the problem of multiple testing.
However, there are obvious differences between F1 and F2 values
between published data and the present control group with higher
F1 values for /a/ and /i/ and lower F2 values for /u/ as the main
discrepancy. Calculation of VAI and tVSA values from the
published data led to comparable results as in the present study,
however, there was an inverse behaviour of VAI and tVSA
between male and female speakers with lower VAI and tVSA
values in the published female group.
Discussion
This study analysed the development of vowel articulation as
one distinctive parameter of speech in the clinical course of PD.
While general motor performance according to UPDRS III
remained relatively stable over time (obviously due to an interim
adaptation of the dopaminergic medication illustrated by an
increase of LEDs between first and second examination), vowel
articulation in Parkinsonian speakers exhibited a significant
deterioration which was not observed in the control group and
therefore can be interpreted as a symptom of disease progression
rather than as an effect of aging although – admittedly – the
average follow-up interval was shorter in the control than in the
PD group. Notwithstanding the widely stable overall motor
performance, the majority of patients featured a decline of gait
function and an increase of H&Y staging between first and second
examination which showed a correlation to the deterioration of
vowel articulation. Therefore, one might argue that the progres-
sive impairment of vowel articulation parallels the progression of
Table 3. Male participants’ characteristics and results.
PD male (n=42) Control male (n=20)
t0 t1 comparison t0 vs. t1 t0 t1 comparison t0 vs. t1
mean S.D. mean S.D. mean S.D. mean S.D.
age 66.27 7.95 68.24 5.09
t0–t1 (months) 35.02 21.27 21.72 6.25
disease duration (months) 73.57 50.44 108.60 55.87
levodopa equivalent dosage (mg) 561 176 751 226 p,0.0001
Hoehn&Yahr 1.99 0.30 2.57 0.67 p,0.0001
UPDRS III 19.48 10.74 19.10 8.28 n.s.
UPDRS speech item 0.96 0.66 1.36 0.87 p,0.05
UPDRS axial score 1.50 1.50 2.83 1.75 p,0.0001
VAI 0.756 0.074 0.680 0.070 p,0.0001 0.774 0.072 0.769 0.075 n.s.
tVSA 52,700 37,495 43,571 36,009 n.s. 66,053 48,151 60,983 43,432 n.s.
n.s.=not significant; S.D.=standard deviation; Hz=hertz.
UPDRS III=Unified Parkinson’s Disease Rating Scale/Motor Score.
VAI=vowel articulation index; tVSA=triangular vowel space area.
doi:10.1371/journal.pone.0032132.t003
Table 4. Female participants’ characteristics and results.
PD female (n=25) Control female (n=20)
t0 t1 comparison t0 vs. t1 t0 t1 comparison t0 vs. t1
mean S.D. mean S.D. mean S.D. mean S.D.
age 65.48 9.26 67.44 7.60
t0–t1 (months) 32.44 19.00 21.01 5.99
disease duration (months) 72.96 61.67 105.40 57.35
levodopa equivalent dosage (mg) 566 152 677 166 p,0.0001
Hoehn&Yahr 2.20 0.41 2.56 0.58 p,0.001
UPDRS III 18.20 11.03 19.20 8.57 n.s.
UPDRS speech item 0.76 0.60 1.20 0.71 p,0.05
UPDRS axial score 1.56 1.26 2.68 1.53 p,0.0001
VAI 0.848 0.064 0.793 0.049 p=0.001 0.889 0.072 0.882 0.069 n.s.
tVSA 171,177 54,258 121,396 35,942 p=0.0003 200,344 64,888 193,763 60,750 n.s.
n.s.=not significant; S.D.=standard deviation; Hz=hertz.
UPDRS III=Unified Parkinson’s Disease Rating Scale/Motor Score.
VAI=vowel articulation index; tVSA=triangular vowel space area.
doi:10.1371/journal.pone.0032132.t004
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augmentation of dopaminergic medication in the course of the
disease.
The vowels for analysis of tVSA and VAI had derived from
different standardized words of a reading task to minimize the
impact of lexical factors as word frequency and phonological
neighborhood density which have been shown to influence vowel
space area [34]. However, since the vowels were extracted from
different phonemes with diverse impact e.g. of coarticulation
phenomena, the calculated average formant frequency values
presumably mirror a composition of slightly diverse vowels rather
than the ‘‘pure’’ corner vowels, though, with identical effects in the
PD and the control group. This methodological aspect might be
the explanation for the differences found between the control
group of the present study and published data from literature
which additionally vary concerning speakers age (which ranged
from 20 to 30 years in the cited study) [33].
The reading task was chosen in order to obtain comparable data
for the acoustical analysis, although it is well known that several
speech modalities as well as overall speech intelligibility are
influenced by the underlying speech task [35,36]. Measurement of
VAI had been previously shown to mirror the reduction of
‘‘working space for vowels’’ as a consequence of articulatory
undershooting in Parkinsonian speakers even before the manifes-
tation of severe speech impairment [3]. However, in the present
study, VAI at t0 showed only a tendency to reduction in male and
female PD patients which featured only mild overall speech
impairment, comparable to the previous investigation of our group
[3]. Therefore, the potential of VAI to serve as a very early marker
of subclinical dysarthria in PD has to be put into perspective and
necessitates further validation. Interestingly, an inverse correlation
between VAI and global speech impairment according to UPDRS
speech item was seen only in the female PD subgroup which
suggests a differential contribution of speech aspects on overall
intelligibility among the genders.
These gender-related differences might be due to the sexual
dimorphism of the laryngo-pharyngeal tractus with different size
and configuration of the tongue, the three dimensional shape and
acoustical properties of vocal cord and the resonatory cavities in
male and female. According to previous studies in healthy
speakers, gender-related differences of overall speech intelligibility
had been attributed to these anatomical factors since fundamental
and formant frequencies as well as the resulting working space for
vowels have been found to vary significantly between healthy men
and women [37–41]. On the other hand, additional to pure
anatomical conditions, gender-differences have been previously
documented concerning disturbed prosody in Parkinsonian
speakers with a relatively stronger reduction of pitch variability,
decreased pause ratio and a tendency to accelerated speech rate in
female PD patients only [41]. This finding could serve as a first
evidence for diverse profiles of dysarthria in male and female PD
speakers which requires further investigation.
One further aim of the current study was the comparison of
VAI and tVSA in the monitoring of vowel articulation over time.
Interestingly, the aforementioned gender-related differences were
also mirrored by the behaviour of tVSA which in female
Parkinsonian speakers showed accordant changes as VAI. Besides,
in female PD patients, VAI and tVSA showed similar correlations
to the UPDRS gait subscore, but only VAI was correlated to the
UPDRS speech item. On the other hand, in the male group, tVSA
featured no significant differences in the course of the disease and
in comparison to male healthy subjects and showed no correlation
to the UPDRS gait subscore. Therefore, VAI seems to be superior
to tVSA especially in male speakers in the earlier stage of PD,
whereas measurement of tVSA and VAI rather seem to be equally
applicable in female speakers, in the later stages and for intra-
individual comparison. However, this preliminary interpretation
of a possible complementary value of tVSA and VAI needs further
validation.
Since in the current investigation, all Parkinsonian speakers were
under different therapeutic regimen, the results allow no conclusion
about a possible effect of dopaminergic stimulation on vowel
articulation, although no correlations were found between vowel
articulation and the LEDs. While augmentation of LEDs between
first and second examination was obviously able to stabilize and
sometimes even ameliorate global motor function in the PD group,
there was an increase of the UPDRS gait subscore which showed a
correlation to the deterioration of vowel articulation in the PD
group. In a similar vein, a previous longitudinal investigation of our
group revealed an analogue pattern of progression of dysprosody in
Parkinsonian speakers – again with some gender-dependent
characteristics - independent from global motor impairment [28],
but in that study, no subscores of the UPDRS were given.
Summarized, these findings give reason to the hypothesis that
impairment of vowel articulation and progressive prosodic changes
could be the result of an escalation of axial dysfunction too subtle to
be mirrored by global UPDRS motor score. Alternatively,
alterations of speech parameters could be completely independent
Figure 3. Comparison of vowel articulation index (VAI) at first
(VAI_t0) and second (VAI_t1) examination. PD=Parkinson’s
disease; contr=control group; m=male; f=female. **=p,0.01.
doi:10.1371/journal.pone.0032132.g003
Figure 4. Comparison of triangular vowel space area (tVSA) at
first (tVSA_t0) and second (tVSA_t1) examination. PD=Parkin-
son’s disease; contr=control group; m=male; f=female. *=p,0.05;
**=p,0.01.
doi:10.1371/journal.pone.0032132.g004
Vowel Articulation in the Course of PD
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e32132from motor performance maybe based upon non-dopaminergic
mechanisms, as it is supported by the lack of an unequivocal
evidenceofspeechameliorationunder levodopaadmission[42–44].
One limitation of the present study is that disease duration on
first examination as well as period of time between the two
examinations were not standardized but lay within a wide range;
therefore, it is not appraisable if progression of vowel articulation
impairment follows the tempo of motor deterioration. Since mean
disease duration on first examination was about 6 years, the
current findings seem to locate the phase of articulatory
deterioration into a more advanced stage of disease, paralleling
the increase of axial symptoms and gait dysfunction. These
estimations find some substantiation by a previous study on speech
impairment in a large sample of patients with PD in different
stages of the disease: While abnormalities of voice were already
present in patients with only mild overall motor impairment,
additional deterioration of articulation and fluency appeared in
the more advanced stages of the disease [23]. On the other hand,
subtle telemetric analyses of different speech variables have been
successfully used to predict the severity of PD in a pilot study on a
large number of 82 patients [45]. However, according to the
present data, worsening of speech performance seem to follow an
individual pace without clear correlation to progression of motor
performance or disease duration, since there were no correlations
between changes of tVSA or VAI and the time period passed
between the visits.
Summarized, the current study together with the afore
mentioned findings justify the assumption that acoustic analyses
of vowel articulation and dysprosody could turn out to become a
useful instrument for the monitoring of non-dopaminergic disease
progression at least in the more advanced stages of PD, since
impairment of vowel articulation was found to parallel the
increasing deterioration of gait. Additional investigations are
needed to clarify and further substantiate a possible differential
value of tVSA and VAI measurement in the different gender and
different stages of disease. Further longitudinal studies with regard
to several distinct speech parameters are warranted with
standardized follow-up examinations to obtain further insight into
pathophysiology and progression of speech impairment in
Parkinson’s disease.
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